Biocon Ltd. (BIOCON) 52 Week Low Streak: Why the Decline Kept Extending

Biocon Ltd. 52 Week Low Streak has now reached its second straight session, with the stock setting another fresh 52-week low and moving down 3.08% across the streak so far. The latest trough is Rs 330, matching the current traded price at 22 October 2026 at 9:22 AM IST. Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.

With a market capitalisation of Rs 55,491.09 crore, Biocon Ltd. 52 Week Low Streak is a useful lens for reading the stock differently from a single-day breakdown. One fresh one-year low can be a brief event; back-to-back lows show a pattern that readers should track with fundamentals, sector standing and valuation in mind. The share price remains the starting point, but the repeated-low pattern is the main signal here.

Biocon Ltd. (BIOCON) 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 330
Previous Close	Rs 333.5
Today's Move	Rs -3.5 (-1.05%)
Open	Rs 335.9
High	Rs 335.9
Low	Rs 330
Market Capitalisation	Rs 55,491.09 crore

Biocon Ltd. (BIOCON) traded at Rs 330 versus the previous close of Rs 333.5, a fall of 1.05%. The stock opened at Rs 335.9, reached a high of Rs 335.9, touched a low of Rs 330.

Biocon Ltd. 52 Week Low Streak also needs to be read through the intraday move. The latest traded price of Rs 330 was Rs 3.5 below the previous close of Rs 333.5, a decline of 1.05% for the session. The stock opened at Rs 335.9, touched the same level as the day’s high, and then moved down to Rs 330, which was also the day’s low and the fresh 52-week low. That placed the latest traded price at the bottom of the day’s range.

For readers following Biocon Ltd. 52 Week Low Streak, the important point is that the session did not recover away from the low. The intraday structure stayed weak from the open onward, and the repeated low now extends the one-year trough into a second straight session. The current market capitalisation of Rs 55,491.09 crore places the stock among sizeable names in the healthcare space, but size alone does not interrupt a decline. The price action analysis shows a stock still being marked lower, not one attempting a rebound.

What the Repeated 52-Week Lows Show

Biocon Ltd. 52 Week Low Streak is best understood as a repeated repricing event rather than a one-off fall. The stock has now set a fresh 52-week low for its second straight session, and the cumulative move across that streak stands at -3.08%. That cumulative figure matters because it captures the full run of weakness, not just the latest daily change. The pattern also shows that the one-year trough has moved lower again, from the previous low on 21 October 2026 to Rs 330 on 22 October 2026.

That comparison is central to Biocon Ltd. 52 Week Low Streak. The new low is not simply another touch of an old floor; it is a lower print than the prior session’s trough, which confirms that the decline is still extending. At this stage, the market data confirms the pattern, but it does not confirm a company-specific trigger. For investors, the key takeaway is the continuation of the downward path, not any technical interpretation or a claim about what the market is thinking.

Biocon Ltd. (BIOCON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 55,491.09 crore
P/E Ratio	109.73x
P/B Ratio	1.6x
ROE	1.35%
ROCE	3.26%
EPS	Rs 3.04
Book Value Per Share	Rs 208.53
Dividend Yield	0.15%

Biocon Ltd. (BIOCON) fundamental metrics show P/E 109.73x, P/B 1.6x, ROE 1.35%, ROCE 3.26%. Read together, these ratios describe the company's position rather than a recommendation.

Biocon Ltd. has a market capitalisation of Rs 55,491.09 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 109.73x, P/B at 1.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.97x, median ROE of 11.43%, median ROCE of 13.26%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	109.73x
Benchmark Median P/E	30.97x
Benchmark Average P/E	45.01x
Benchmark P/E Range	3.4x to 616.23x
Company P/B Ratio	1.6x
Benchmark Median P/B	2.72x
Company ROE	1.35%
Benchmark Median ROE	11.43%
Company ROCE	3.26%
Benchmark Median ROCE	13.26%
Company Market Capitalisation	Rs 55,491.09 crore
Benchmark Median Market Cap	Rs 768.75 crore

Biocon Ltd. (BIOCON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Biocon Ltd. (BIOCON) has a P/E ratio of 109.73x, which is above the benchmark median of 30.97x, a difference of +254.31%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.43%, a difference of -88.19%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.26%, a difference of -75.41%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Abbott India Ltd.	ABBOTINDIA	54,909.79	33.88	10.57	34.67	46.72
Alkem Laboratories Ltd.	ALKEM	59,722.72	27.52	4.15	18.29	21.28
Gland Pharma Ltd.	GLAND	49,952.91	42.75	4.54	10.56	14.96
Glenmark Pharmaceuticals Ltd.	GLENMARK	62,339.2	34.61	5.68	14.1	20.35
Ipca Laboratories Ltd.	IPCALAB	46,049.85	37.13	5.73	15.88	19.41

Biocon Ltd. (BIOCON) has a P/E ratio of 109.73x compared with the displayed peer median of 34.61x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 1.35% compares with a peer median of 15.88% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 55,491.09 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Biocon Ltd.

• Biocon Ltd. 52 Week Low Streak has now run for two straight sessions, so investors are tracking whether the decline keeps extending or stabilises.
• The cumulative move across the streak is -3.08%, which is more informative than the latest daily change alone.
• The stock’s P/E of 109.73 remains far above the industry median of 30.97, even after the repeated low.
• ROE of 1.35% and ROCE of 3.26% remain well below the industry medians, so the return profile stays weak relative to the benchmark.
• The current price of Rs 330 is the latest 52-week low, so readers will want to see whether any future session prints a higher low.

About Biocon Ltd.

Biocon Ltd. 52 Week Low Streak should be read in the context of a healthcare and pharmaceuticals business with a large market capitalisation and a broad industry presence. The company operates in Pharmaceuticals & Drugs, where valuation often depends on earnings quality, return ratios and the durability of the business model. Here, the key figures for readers are the P/E, P/B, ROE and ROCE rather than a generic company description.

For this streak article, the business context matters because the share price has moved to a lower one-year trough while the underlying financial base remains unchanged over the short run. That is why Biocon Ltd. 52 Week Low Streak is more than a price headline. It is a snapshot of how the market is valuing the company against its own history, its sector benchmark and its peers at the moment of repeated lows.

Track Biocon Ltd. Share Price on Univest

Use Biocon Ltd. (BIOCON) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Biocon Ltd. 52 Week Low Streak will stay relevant as long as the stock keeps printing fresh lows or begins to stabilise above the latest trough. Readers can track the live share price, the one-year low path and the latest company updates on the Biocon Ltd. stock page. The main question next is whether the repeated-low pattern continues or pauses.

Frequently Asked Questions

What does Biocon Ltd. 52 Week Low Streak mean?

Ans. It means Biocon Ltd. has set a fresh 52-week low for consecutive sessions. In this case, the stock has done so for the second straight session, which signals a repeated downside pattern rather than a one-day event.

How many sessions has Biocon Ltd. made a new one-year low?

Ans. Biocon Ltd. 52 Week Low Streak has lasted for two consecutive sessions.

What is the cumulative move in Biocon Ltd. 52 Week Low Streak?

Ans. The cumulative move across Biocon Ltd. 52 Week Low Streak is -3.08%. That figure captures the full streak, not just the latest session’s change, and it is the most useful number for reading the repeated decline.

What is the latest 52-week low for Biocon Ltd.?

Ans. The latest 52-week low for Biocon Ltd. is Rs 330. The current traded price is also Rs 330, so the stock is sitting right at the fresh one-year trough during the latest session.

Is a company-specific cause confirmed for the repeated lows?

Ans. No company-specific cause is confirmed here. Biocon Ltd. 52 Week Low Streak is a confirmed market pattern, but the available facts do not establish why the stock has kept setting lower one-year lows.

How does Biocon Ltd. compare with sector valuation?

Ans. Biocon Ltd. trades at a P/E of 109.73 versus the industry median of 30.97. Its P/B of 1.6 is below the industry median of 2.72, while ROE and ROCE are also below the sector benchmark.

How does Biocon Ltd. compare with peers on returns?

Ans. Biocon Ltd. has lower ROE and ROCE than the peer companies listed in the same industry set. That places Biocon Ltd. 52 Week Low Streak at the weaker end of the group on return generation.

Why is the P/E still high after the drop?

Ans. The P/E remains high because the earnings base is still modest relative to the share price level. Biocon Ltd. 52 Week Low Streak lowers the price, but it does not instantly change earnings, so the ratio stays elevated.

What should investors monitor next in Biocon Ltd. 52 Week Low Streak?

Ans. Investors should monitor whether the stock keeps printing lower one-year lows or begins to hold above Rs 330. The streak itself, the valuation gap and the return ratios are the main facts to watch next.